BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9307717)

  • 1. All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines.
    Copper MP; Klaassen I; Brakenhoff RH; Cloos J; Snow GB; Braakhuis BJ
    Oral Oncol; 1997 Jul; 33(4):270-4. PubMed ID: 9307717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
    Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R
    Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines.
    Klaassen I; Brakenhoff RH; Smeets SJ; Snow GB; Braakhuis BJ
    Int J Cancer; 2001 Jun; 92(5):661-5. PubMed ID: 11340568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
    Wan H; Oridate N; Lotan D; Hong WK; Lotan R
    Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
    Zou CP; Hong WK; Lotan R
    Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
    Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
    Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
    Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
    Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.
    Xu XC; Liu X; Tahara E; Lippman SM; Lotan R
    Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
    Lotan R
    Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines.
    Hayashi K; Yokozaki H; Naka K; Yasui W; Yajin K; Lotan R; Tahara E
    Cancer Lett; 2000 Apr; 151(2):199-208. PubMed ID: 10738115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
    Lotan R
    Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid 4-hydroxylase-mediated catabolism of all-trans retinoic acid and the cell proliferation in head and neck squamous cell carcinoma.
    Kim SY; Yoo SJ; Kwon HJ; Kim SH; Byun Y; Lee KS
    Metabolism; 2002 Apr; 51(4):477-81. PubMed ID: 11912557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.
    Youssef EM; Lotan D; Issa JP; Wakasa K; Fan YH; Mao L; Hassan K; Feng L; Lee JJ; Lippman SM; Hong WK; Lotan R
    Clin Cancer Res; 2004 Mar; 10(5):1733-42. PubMed ID: 15014026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate control of growth and cytokeratin 13 expression by retinoic acid.
    Kim SY; Berger D; Yim SO; Sacks PG; Tainsky MA
    Mol Carcinog; 1996 May; 16(1):6-11. PubMed ID: 8634095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
    van der Leede BM; van den Brink CE; van der Saag PT
    Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype.
    Higuchi E; Chandraratna RA; Hong WK; Lotan R
    Oncogene; 2003 Jul; 22(30):4627-35. PubMed ID: 12879006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.